Form 4: Quoin Pharmaceuticals CEO Michael Myers Increases Stake in Company
SEC Form 4
CEO Michael Myers recently acquired additional ordinary shares of Quoin Pharmaceuticals, Ltd. through a series of transactions.
Summary
- Michael Myers, the CEO of Quoin Pharmaceuticals, has reported changes in his beneficial ownership of the company's ordinary shares.
- On September 3, 2024, Myers acquired 800 ordinary shares at a price of $0.619 per share.
- On September 4, 2024, he acquired 5,322 shares at $0.6558, 8,200 shares at $0.7481, and 23,572 shares at $0.7974.
- Following these transactions, Myers directly owns 47,252 ordinary shares.
- These shares are represented by American Depositary Shares (ADSs), with each ADS representing one ordinary share after a reverse split.
- The reporting person signed the document on September 5, 2024.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the CEO is increasing their stake in the company, which is generally seen as a good sign. However, the document itself is just a regulatory filing, so the sentiment isn't extremely high.
Positives
- The CEO's increased investment in the company may signal confidence in Quoin Pharmaceuticals' future prospects.
Industry Context
Tracking insider transactions is a common practice in the financial industry to gauge management's sentiment about the company's prospects. An increase in share ownership by a CEO is often viewed positively.
Stakeholder Impact
- The CEO's increased stake could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| July 18, 2023 | Ratio of ADSs evidencing ordinary shares changed from 1 ADS representing five thousand (5,000) ordinary shares to 1 ADS representing sixty thousand (60,000) ordinary shares, which resulted in a 1 for 12 reverse split of the issued and outstanding ADSs. |
| November 8, 2023 | The Issuer completed a 1 for 60,000 reverse split of the ordinary shares which resulted in the ratio of ADSs evidencing ordinary shares to be changed from 1 ADS representing sixty thousand (60,000) ordinary shares to 1 ADS representing one (1) ordinary share. |
| September 3, 2024 | Michael Myers acquired 800 ordinary shares. |
| September 4, 2024 | Michael Myers acquired 5,322, 8,200, and 23,572 ordinary shares. |
| September 5, 2024 | Date of signature on the SEC Form 4. |
Keywords
Quoin Pharmaceuticals, Michael Myers, Ordinary Shares, Beneficial Ownership, SEC Form 4, QNRX, ADS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.